| Joel Tonagel, CRNA | |
|
814 Laporte Ave, Valparaiso, IN 46383 | |
| (219) 465-4600 | |
| Not Available |
| Full Name | Joel Tonagel |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | 814 Laporte Ave, Valparaiso, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083976153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 89909 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
| Pinnacle Hospital | Crown point, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Joseph Regional Medical Center-south Bend Campus Inc | 3476451790 | 77 |
| Sda Consultants Pllc | 3870825912 | 16 |
| Jebs Anesthesia Consultants, Llc | 4486046646 | 30 |
| Stat Anesthesia Specialists Ltd | 8123031473 | 23 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Saint Joseph Regional Medical Center-south Bend Campus Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841245594 PECOS PAC ID: 3476451790 Enrollment ID: O20031223000724 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Porter County Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215974936 PECOS PAC ID: 4789573411 Enrollment ID: O20040311001120 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Stat Anesthesia Specialists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699724781 PECOS PAC ID: 8123031473 Enrollment ID: O20070529000372 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Centers For Pain Control, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790920452 PECOS PAC ID: 7416019450 Enrollment ID: O20081229000343 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Anesthesia Associates Of Laporte Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235455429 PECOS PAC ID: 3779614508 Enrollment ID: O20100623000427 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Indiana Ams Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275018236 PECOS PAC ID: 3971857897 Enrollment ID: O20181113001456 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Sda Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336605500 PECOS PAC ID: 3870825912 Enrollment ID: O20210819003335 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Entity Name | Jebs Anesthesia Consultants, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790447761 PECOS PAC ID: 4486046646 Enrollment ID: O20220120000233 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel Tonagel, CRNA 2906 Blue Grouse St, Valparaiso, IN 46383-7085 Ph: () - | Joel Tonagel, CRNA 814 Laporte Ave, Valparaiso, IN 46383 Ph: (219) 465-4600 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Hythiam, Inc. announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
› Verified 1 days ago
Patrick Dickinson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6, Valparaiso, IN 46383 Phone: 219-983-5743 Fax: 219-983-5994 | |
Callan Gannon Jones, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 83 E Us-6 Frontage Road, Valparaiso, IN 46383 Phone: 219-983-8300 | |
Dr. Charles Cooper, DNP CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6, Valparaiso, IN 46383 Phone: 219-263-4600 | |
Mr. Jonathan Paul Skrabak, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6, Valparaiso, IN 46383 Phone: 219-983-5743 Fax: 219-983-5994 | |
Julie Andrea Mitchener, DNP CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6, Valparaiso, IN 46383 Phone: 219-263-4600 | |
William K Mitchell V, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 85 E Us-6 Frontage Rd, Valparaiso, IN 46385 Phone: 219-983-8300 |